TWiV 608: Daniel Griffin's COVID-19 clinical report episode artwork

EPISODE · May 1, 2020 · 57 MIN

TWiV 608: Daniel Griffin's COVID-19 clinical report

from This Week in Virology · host Vincent Racaniello

Daniel Griffin updates the clinical situation with COVID-19 patients, followed by analysis of the remedesivir clinical trial results, and answers listener questions. Hosts: Vincent Racaniello and Rich Condit Guest: Daniel Griffin Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Pulmonary embolism in COVID-19 (Emerg Inf Dis) Patch Study Remdesivir in adults with severe COVID-19 (Lancet) ACTT remdesivir trial (NIAID) Commentary on remdesivir trials (Lancet) FDA expected to issue remdesivir EUA (Contaigon Live) Recovered COVID-19 patients wrong (Korea Herald) Letters read on TWiV 608 Image credit Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees. Send your virology questions and comments to [email protected]

Episode metadata supplied by the publisher feed · Published May 1, 2020

Embed this episode

NOW PLAYING

TWiV 608: Daniel Griffin's COVID-19 clinical report

0:00 57:12

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of This Week in Virology?

This episode is 57 minutes long.

When was this This Week in Virology episode published?

This episode was published on May 1, 2020.

Can I download this This Week in Virology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!